ACIT v. Intas Pharmaceuticals Ltd. (2025) 236 TTJ 550/ 174 taxmann.com 867 (Ahd)(Trib)

S. 35: Expenditure on scientific research-Approval of DSIR-In the absence of any statutory requirement for the DSIR to quantify or approve each expense prior to 1st July, 2016, the claim of weighted deduction under S. 35(2AB) cannot be restricted to the amount mentioned in Form No. 3CL. [S. 35(2AB]

Held that in the absence of any statutory requirement for the DSIR to quantify or approve each expense prior to 1st July, 2016, the claim of weighted deduction under s. 35(2AB) cannot be restricted to the amount mentioned in Form No. 3CL; since the other expenditure was incurred by erstwhile CB Ltd., which has merged with the assessee-company and was granted recognition by DSIR, the said expenditure is eligible for weighted deduction under s. 35(2AB).(AY. 2015-16)

Leave a Reply

Your email address will not be published. Required fields are marked *

*